“Cancer is a complex and devastating disease. There is still a lot we don’t know about how and who it strikes. Continued research will allow us to better understand its complexities so we can prevent the trauma it brings to individuals and their families.”
Program Leader, Professor Stephen Ackland
The HMRI Cancer Program is represented by approximately 120 researchers from the University of Newcastle, Hunter New England Health and Calvary Mater Newcastle, united by the common goal to prevent and find more effective treatments for cancer.
Bringing together basic science and clinical researchers, the Cancer Program aims to reduce the incidence of cancer and to create effective therapies by tailoring treatments to the genetic profile of the disease, and to individual patients’ needs. From understanding the biology of cancer and developing more effective cancer therapies, through to evaluating therapies through clinical trials, researchers are aiming to reduce the impact of cancer in our community.
The Cancer Program is made up of a number of specialty research groups. Each group is a multidisciplinary team of clinicians, academics, statisticians working to improve our understanding of and better treat and prevent disease.
